Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
To amend the Internal Revenue Code of 1986 to repeal the unearned income medicare contribution.
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
Food Safety; PAMTA (S. 619 & HR 1549); Child Nutrition; Veterinary Medicine Issues; Veterinary Medicine Appropriations; Veterinarian Capabilities Legislation - Loan Repayment (HR 2999);
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2018 · first_quarter · 1A
Sanitary and phytosanitary issues (SPS); Japan; Turkey (country) Pricing; IPR and Pricing; Canada IP; NAFTA renegotiation; Colombia OELD Accession
Issues related to animal health, antibiotics, veterinary medicine, and food safety - no specific legislation; Preservation of Antibiotics for Medical Treatment Act of 2017; Issues related to Animal Drug User Fee Act (ADUFA); Codex Alimentarius Commission (Food Safety, Animal Health Issues); Issues related to animal health and food safety - no specific legislation; Implementation of biotechnology policy - no specific legislation; Issues related to veterinary biologics - no specific legislation
Source: Senate LDA
Food Safety; PAMTA (S. 619 & HR 1549); Child Nutrition; Veterinary Medicine Issues; Veterinary Medicine Appropriations; Veterinarian Capabilities Legislation - Loan Repayment (HR 2999);
Fairness in Cocaine Sentencing Act of 2009
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
Veterinary medicine / antibiotic legislation (HR 1459, HR 2400, S 619) / biologics; food safety
Preservation of Antibiotics for Medical Treatment Act of 2009
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
Veterinary medicine/antibiotics (S 619 & HR 1549), CVB budget; food safety; Child Nutrition Act reauthorization; PAMTA (HR 1549)
Preservation of Antibiotics for Medical Treatment Act of 2009
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
Food safety (S 510); PAMTA (S 619, HR 1549); Veterinary Medicine Public Health/Loan Repayment Act (S 3621. HR 2999); Veterinary Medicines; Appropriations
Strategies to Address Antimicrobial Resistance Act
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
Veterinary medicine / antibiotic legislation (HR 1459, HR 2400, S 619) / biologics; food safety
China IP; US-Japan trade and reforms; KORUS; Korea reform; Taiwan reform; HR 252; Veterinary medicine trade matters; Brazil WTO Cotton case; Special 301
Veterinary Public Health Amendments Act of 2010
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
Food safety (S 510); PAMTA (S 619, HR 1549); Veterinary Medicine Public Health/Loan Repayment Act (S 3621. HR 2999); Veterinary Medicines; Appropriations
Veterinary Public Health Amendments Act of 2010
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
Food Safety (S 510); PAMTA (S 619, R 1549); Veterinary Medicines/Appropriations; Child Nutrition (S 3307), Veterinary Capabilities Legislation-Loan Repayment (HR 2999)
America's Affordable Health Choices Act of 2009
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
Medicare reimbursement and coverage policies; Healthcare reform (HR 3590 & HR 4872); food safety; Patient Protection and Affordable Care Act (HR 3590); FOB provisions (HR 3200)
Veterinary Medicine Loan Repayment Program Enhancement Act
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
Food safety (S 510); PAMTA (S 619, HR 1549); Veterinary Medicine Public Health/Loan Repayment Act (S 3621. HR 2999); Veterinary Medicines; Appropriations
Food Safety (S 510); PAMTA (S 619, R 1549); Veterinary Medicines/Appropriations; Child Nutrition (S 3307), Veterinary Capabilities Legislation-Loan Repayment (HR 2999)
Food safety (S 510); PAMTA (S 619, HR 1549); Veterinary Medicine Public Health/Loan Repayment Act (S 3621. HR 2999); Veterinary Medicines; Appropriations
Food safety (S 510); Food safety interventions
Food Safety (S 510); Food safety interventions - USDA
Preservation of Antibiotics for Medical Treatment Act of 2009
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
Food safety (S 510); PAMTA (S 619, HR 1549); Veterinary Medicine Public Health/Loan Repayment Act (S 3621. HR 2999); Veterinary Medicines; Appropriations
Preservation of Antibiotics for Medical Treatment Act of 2009
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
Food Safety (S 510); PAMTA (S 619, R 1549); Veterinary Medicines/Appropriations; Child Nutrition (S 3307), Veterinary Capabilities Legislation-Loan Repayment (HR 2999)
Preservation of Antibiotics for Medical Treatment Act of 2009
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
Veterinary medicine / antibiotic legislation (HR 1459, HR 2400, S 619) / biologics; food safety
Preservation of Antibiotics for Medical Treatment Act of 2009
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
Veterinary medicine/antibiotics (S 619 & HR 1549), CVB budget; food safety; Child Nutrition Act reauthorization; PAMTA (HR 1549)
American Middle Class Tax (AMT) Relief Act of 2007
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
Medicare reimbursement and coverage policies; Healthcare reform (HR 3590 & HR 4872); food safety; Patient Protection and Affordable Care Act (HR 3590); FOB provisions (HR 3200)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
Medicare reimbursement and coverage policies; Healthcare reform (HR 3590 & HR 4872); food safety; Patient Protection and Affordable Care Act (HR 3590); FOB provisions (HR 3200)
Preservation of Antibiotics for Medical Treatment Act of 2009
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
Veterinary Antibotics (S 619 & HR 1549)
Preservation of Antibiotics for Medical Treatment Act of 2009
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
Preservation of antibiotics for medical treatment act (HR 1549, S 619); Food safety enhancement act (HR 2749); Food safety modernization act (S 510); Strategies to address antimicrobial act (HR 2400); Veterinary services investment act (S 1709, HR 3519)
Preservation of Antibiotics for Medical Treatment Act of 2009
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
Veterinary medicine; Preservation of Antibiotics for Medical Treatment Act (HR 1549, S 619); Food Safety Modernization Act (S 510); Food Safety Enhancement Act (HR 2749); Strategies to Address Antimicrobial Resistance Act (HR 2400)
Preservation of Antibiotics for Medical Treatment Act of 2009
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
Antibiotic legislation (HR 1549, S 619)
Strategies to Address Antimicrobial Resistance Act
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
Veterinary medicine; Preservation of Antibiotics for Medical Treatment Act (HR 1549, S 619); Food Safety Modernization Act (S 510); Food Safety Enhancement Act (HR 2749); Strategies to Address Antimicrobial Resistance Act (HR 2400)
Strategies to Address Antimicrobial Resistance Act
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
Preservation of antibiotics for medical treatment act (HR 1549, S 619); Food safety enhancement act (HR 2749); Food safety modernization act (S 510); Strategies to address antimicrobial act (HR 2400); Veterinary services investment act (S 1709, HR 3519)
Food Safety Enhancement Act of 2009
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
Child Nutrition Reauthorization (HR 2997); Food Safety Modernization Act (S 510); Food Safety Enhancement Act (HR 2749)
Food Safety Enhancement Act of 2009
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
Child Nutrition Act Reauthorization, Food Safety (S 510, HR 2749)
Food Safety Enhancement Act of 2009
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
Veterinary medicine; Preservation of Antibiotics for Medical Treatment Act (HR 1549, S 619); Food Safety Modernization Act (S 510); Food Safety Enhancement Act (HR 2749); Strategies to Address Antimicrobial Resistance Act (HR 2400)
Food Safety Enhancement Act of 2009
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
Preservation of antibiotics for medical treatment act (HR 1549, S 619); Food safety enhancement act (HR 2749); Food safety modernization act (S 510); Strategies to address antimicrobial act (HR 2400); Veterinary services investment act (S 1709, HR 3519)
Veterinarian Services Investment Act
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
Preservation of antibiotics for medical treatment act (HR 1549, S 619); Food safety enhancement act (HR 2749); Food safety modernization act (S 510); Strategies to address antimicrobial act (HR 2400); Veterinary services investment act (S 1709, HR 3519)
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2010
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
Japan bilateral trade architecture; reimbursement and regulatory reform, China IP; Korea FTA reimbursement & pricing reform; Taiwan TIFA and reimbursement & pricing reform; Indonesia investment decree; Philippines pricing reform; Thailand healthcare system reform; Agriculture (HR 2997, S 1406); Rural development; Food and Drug Administration Appropriations Act for 2010; China meat & poultry issues; Russia meat & poultry issues; UK meat & poultry issues; CODEX Alimentarius; Turkey pricing; Russia IP; A;geria market access; Brazil IP; Mexico IP; Argentina IP; Chile IP; Columbia IP; Peru IP; Isreal IP; Saudi Arbia pricing and IP
Veterinary Services Investment Act
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
Preservation of antibiotics for medical treatment act (HR 1549, S 619); Food safety enhancement act (HR 2749); Food safety modernization act (S 510); Strategies to address antimicrobial act (HR 2400); Veterinary services investment act (S 1709, HR 3519)
Title I Education Funding Integrity Act of 2009
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
Anti-counterfeiting; Anti-counterfeiting Trade Agreement (ACTA); Ambassadorial nominations for the UN, US_ASEAN Summit; Canada S. 242 and intellectual property (IP); Mexico IP; Peru FTA; Columbia FTA; Algeria access; UK pricing; Germany HC reform; Saudi Arabia access/IP; Cuba sanctions; Argentina access and IP; Poland WTO; Russia WTO; Turkey access; Brazil trade negotiations; Japan pricing and regulatory reform; China IPR; Korea pricing reform and FTA; Taiwan pricing reform; Agriculture Appropriations/Trade Provisions (HR 2997)
Child Nutrition Reauthorization (HR 2997); Food Safety Modernization Act (S 510); Food Safety Enhancement Act (HR 2749)
Child Nutrition Act Reauthorization, Food Safety (S 510, HR 2749)
Preservation of antibiotics for medical treatment act (HR 1549, S 619); Food safety enhancement act (HR 2749); Food safety modernization act (S 510); Strategies to address antimicrobial act (HR 2400); Veterinary services investment act (S 1709, HR 3519)
Veterinary medicine; Preservation of Antibiotics for Medical Treatment Act (HR 1549, S 619); Food Safety Modernization Act (S 510); Food Safety Enhancement Act (HR 2749); Strategies to Address Antimicrobial Resistance Act (HR 2400)
Preservation of Antibiotics for Medical Treatment Act of 2009
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
Preservation of antibiotics for medical treatment act (HR 1549, S 619); Food safety enhancement act (HR 2749); Food safety modernization act (S 510); Strategies to address antimicrobial act (HR 2400); Veterinary services investment act (S 1709, HR 3519)
Preservation of Antibiotics for Medical Treatment Act of 2009
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
Veterinary medicine; Preservation of Antibiotics for Medical Treatment Act (HR 1549, S 619); Food Safety Modernization Act (S 510); Food Safety Enhancement Act (HR 2749); Strategies to Address Antimicrobial Resistance Act (HR 2400)
Preservation of Antibiotics for Medical Treatment Act of 2009
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
Veterinary Antibotics (S 619 & HR 1549)
Preservation of Antibiotics for Medical Treatment Act of 2009
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
Antibiotic legislation (HR 1549, S 619)
Anti-counterfeiting; Anti-counterfeiting Trade Agreement (ACTA); Ambassadorial nominations for the UN, US_ASEAN Summit; Canada S. 242 and intellectual property (IP); Mexico IP; Peru FTA; Columbia FTA; Algeria access; UK pricing; Germany HC reform; Saudi Arabia access/IP; Cuba sanctions; Argentina access and IP; Poland WTO; Russia WTO; Turkey access; Brazil trade negotiations; Japan pricing and regulatory reform; China IPR; Korea pricing reform and FTA; Taiwan pricing reform; Agriculture Appropriations/Trade Provisions (HR 2997)
Child Nutrition Reauthorization (HR 2997); Food Safety Modernization Act (S 510); Food Safety Enhancement Act (HR 2749)
Japan bilateral trade architecture; reimbursement and regulatory reform, China IP; Korea FTA reimbursement & pricing reform; Taiwan TIFA and reimbursement & pricing reform; Indonesia investment decree; Philippines pricing reform; Thailand healthcare system reform; Agriculture (HR 2997, S 1406); Rural development; Food and Drug Administration Appropriations Act for 2010; China meat & poultry issues; Russia meat & poultry issues; UK meat & poultry issues; CODEX Alimentarius; Turkey pricing; Russia IP; A;geria market access; Brazil IP; Mexico IP; Argentina IP; Chile IP; Columbia IP; Peru IP; Isreal IP; Saudi Arbia pricing and IP
Agriculture Appropriations/MAP-FMD Funding (HR 2997)
Pharmaceutical Market Access and Drug Safety Act of 2007
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
Veterinary Medicine Market Access; Czech Republic (market access & pricing reform); European Union (Pharmaceutical Package legislation); Finland (IP); Germany (pricing & health care reform); Italy (pricing & health care reform); Norway (IP & market access); Poland (market access); Slovakia (IP & market access); Sweden (pricing & health care reform); United Kingdon (pricing & health care reform); Anti-Counterfeiting Trade Agreement; Latin America Free Trade Agreements; (CONTINUED ON NEXT PAGE) Canada (Pharmaceutical Market Access and Drug Safety Act - S 242 & access restrictions & IP); Cuba (omnibus bill & sanctions); Mexico (IP & market access); Brazil (IP & market access); Algeria (IP & access restrictions); Tunisia (IP & access restrictions); Egypt (IP); Saudia Arabia (IP & access restrictions); Peru (FTA Implementation); Argentina (IP & access restrictions); Chili (IP); Turkey (IP & access restrictions); Russia (IP & WTO accession); Israel (IP); Columbia (IP); South Africa (access restrictions); Japan (pricing & regulatory reform); China (anti-counterfeiting & pricing reform); Taiwan (pricing reform & IP); Korea (pricing reform); Thailand (CL); Indonesia (investment decree); Philippines (pricing reform);
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2018 · third_quarter · 3A
Issues related to animal health, antibiotics, veterinary medicine, and food safety - no specific legislation; Preservation of Antibiotics for Medical Treatment Act of 2017; Issues related to Animal Drug User Fee Act (ADUFA); Codex Alimentarius Commission (Food Safety, Animal Health Issues); Issues related to animal health and food safety - no specific legislation; Implementation of biotechnology policy - no specific legislation; Issues related to veterinary biologics - no specific legislation
Sanitary and phytosanitary issues (SPS); Japan; Turkey (country) Pricing; IPR and Pricing; Canada IP; NAFTA renegotiation; Colombia OELD Accession
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2018 · third_quarter · Q3
Issues related to animal health, antibiotics, veterinary medicine, and food safety - no specific legislation; Preservation of Antibiotics for Medical Treatment Act of 2017; Issues related to Animal Drug User Fee Act (ADUFA); Codex Alimentarius Commission (Food Safety, Animal Health Issues); Issues related to animal health and food safety - no specific legislation; Implementation of biotechnology policy - no specific legislation; Issues related to veterinary biologics - no specific legislation
Sanitary and phytosanitary issues (SPS); Japan; Turkey (country) Pricing; IPR and Pricing; Canada IP; NAFTA renegotiation; Colombia OELD Accession
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2018 · second_quarter · Q2
Issues related to animal health, antibiotics, veterinary medicine, and food safety - no specific legislation; Preservation of Antibiotics for Medical Treatment Act of 2017; Issues related to Animal Drug User Fee Act (ADUFA); Codex Alimentarius Commission (Food Safety, Animal Health Issues); Issues related to animal health and food safety - no specific legislation; Implementation of biotechnology policy - no specific legislation; Issues related to veterinary biologics - no specific legislation
Sanitary and phytosanitary issues (SPS); Japan; Turkey (country) Pricing; IPR and Pricing; Canada IP; NAFTA renegotiation; Colombia OELD Accession
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2018 · first_quarter · Q1
Sanitary and phytosanitary issues (SPS); Japan; Turkey (country) Pricing; IPR and Pricing; Canada IP; NAFTA renegotiation; Colombia OELD Accession
Issues related to animal health, antibiotics, veterinary medicine, and food safety - no specific legislation; Preservation of Antibiotics for Medical Treatment Act of 2017; Issues related to Animal Drug User Fee Act (ADUFA); Codex Alimentarius Commission (Food Safety, Animal Health Issues); Issues related to animal health and food safety - no specific legislation; Implementation of biotechnology policy - no specific legislation; Issues related to veterinary biologics - no specific legislation
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2017 · fourth_quarter · 4A
Veterinary medicine; Antibiotic issues; Food safety; ADUFA; Codex
Sanitary and phytosanitary issues (SPS); Japan; Turkey Pricing; IPR and Pricing; Canada IP; NAFTA renegotiation; Colombia OELD Accession
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2017 · fourth_quarter · 4A
Veterinary medicine; Antibiotic issues; Food safety; GMO labeling; ADUFA
Sanitary and phytosanitary issues (SPS); Japan; Turkey Pricing; IPR and Pricing; Canada IP; NAFTA renegotiation; Colombia OELD Accession
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2017 · fourth_quarter · Q4
Sanitary and phytosanitary issues (SPS); Japan; Turkey Pricing; IPR and Pricing; Canada IP; NAFTA renegotiation; Colombia OELD Accession
Veterinary medicine; Antibiotic issues; Food safety; GMO labeling; ADUFA
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2017 · third_quarter · 3A
Veterinary medicine; Antibiotic issues; Food safety; GMO labeling; ADUFA
Sanitary and phytosanitary issues (SPS); Japan; Turkey Pricing; IPR and Pricing; Canada IP; NAFTA renegotiation; Colombia OELD Accession
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2017 · third_quarter · Q3
Sanitary and phytosanitary issues (SPS); Japan; Turkey Pricing; IPR and Pricing; Canada IP; NAFTA renegotiation; Colombia OELD Accession
Veterinary medicine; Antibiotic issues; Food safety; GMO labeling; ADUFA
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2017 · second_quarter · Q2
Veterinary medicine; Antibiotic issues; Food safety; GMO labeling; ADUFA
Sanitary and phytosanitary issues (SPS); Japan; Turkey Pricing; IPR and Pricing; Canada IP; NAFTA renegotiation; Colombia OELD Accession
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2017 · first_quarter · Q1
Sanitary and phytosanitary issues (SPS); TPA; Japan; Turkey Pricing; IPR and Pricing; Canada IP; NAFTA renegotiation; Colombia OELD Accession
Veterinary medicine; Antibiotic issues; Food safety; GMO labeling; ADUFA
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2016 · second_quarter · 2A
Sanitary and phytosanitary issues (SPS); TPA; Japan; Turkey Pricing; IPR and Pricing; CODEX; Canada IP; Transatlantic Trade & Investment Partnership; Trans-Pacific Partnership
Veterinary medicine; Antibiotic isuses; Food safety; GMO Labeling
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2016 · fourth_quarter · Q4
Sanitary and phytosanitary issues (SPS); TPA; Japan; Turkey Pricing; IPR and Pricing; CODEX; Canada IP; Transatlantic Trade & Investment Partnership; Trans-Pacific Partnership
Veterinary medicine; Antibiotic isuses; Food safety; GMO Labeling; ADUFA
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2016 · second_quarter · 2A
Sanitary and phytosanitary issues (SPS); TPA; Japan; Turkey Pricing; IPR and Pricing; CODEX; Canada IP; Transatlantic Trade & Investment Partnership; Trans-Pacific Partnership
Veterinary medicine; Antibiotic isuses; Food safety; GMO Labeling
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2016 · third_quarter · Q3
Sanitary and phytosanitary issues (SPS); TPA; Japan; Turkey Pricing; IPR and Pricing; CODEX; Canada IP; Transatlantic Trade & Investment Partnership; Trans-Pacific Partnership
Veterinary medicine; Antibiotic isuses; Food safety; GMO Labeling
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2016 · second_quarter · Q2
Veterinary medicine; Antibiotic isuses; Food safety; GMO Labeling
Sanitary and phytosanitary issues (SPS); TPA; Japan; Turkey Pricing; IPR and Pricing; CODEX; Canada IP; Transatlantic Trade & Investment Partnership; Trans-Pacific Partnership
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2016 · first_quarter · Q1
Veterinary medicine; Antibiotic isuses; Food safety
Sanitary and phytosanitary issues (SPS); TPA; Japan; Turkey Pricing; IPR and Pricing; CODEX; Canada IP; Transatlantic Trade & Investment Partnership
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2015 · fourth_quarter · Q4
Sanitary and phytosanitary issues (SPS); TPA; Japan; Turkey Pricing; IPR and Pricing; CODEX; Canada IP; Transatlantic Trade & Investment Partnership, TPP
Veterinary medicine; Antibiotic isuses; Food safety
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2015 · third_quarter · Q3
Sanitary and phytosanitary issues (SPS); TPA; Japan; Turkey Pricing; IPR and Pricing; CODEX; Canada IP; Transatlantic Trade & Investment Partnership, TPP
Veterinary medicine; Antibiotic isuses; Food safety
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2013 · second_quarter · Q2
Food safety intervention
Veterinary medicine; Antibiotic issues; Food safety
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2013 · second_quarter · Q2
Veterinary medicine; Antibiotics issues; Food safety
Food safety intervention
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2013 · first_quarter · Q1
Food safety intervention
Veterinary medicine; Antibiotics issues; Food safety
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2012 · fourth_quarter · Q4
Food safety intervention
Veterinary medicine; Antibiotics issues; Food safety
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2012 · third_quarter · Q3
Veterinary medicine; Antibiotics issues; Food safety
Food safety intervention
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2012 · second_quarter · Q2
Veterinary medicine; Antibiotics issues; Food safety;
Food safety intervention
Sanitary and Phytosanitary issues (SPS); TPP, Japan; KORUS; Russia PNTR; Turkey pricing; IPR and Pricing; Germany pricing reforms; Poland market access; Spain IP/Pricing; Patent Protection
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2012 · first_quarter · Q1
Food Safety Intervention
Veterinary Medicine; Antibiotic Issues; Food Safety
SPS Issues; Veterinary Medicine; TPP; Russia PNTR; Turkey Pricing; IPR and Pricing; Germany Pricing Reforms; Poland Market Access; Greece Pricing Reform; Spain IP/Pricing
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2011 · fourth_quarter · Q4
Food Safety; PAMTA (S. 619 & HR 1549); Child Nutrition; Veterinary Medicine Issues; Veterinary Medicine Appropriations; Veterinarian Capabilities Legislation - Loan Repayment (HR 2999);
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2011 · third_quarter · Q3
Trans-Pacific Partnership Agreement; Korean Free trade Agreement; TPP IP/Market Access; ASEAN Countries Market Access/IP; IMF Policy on Greece; Veterinary medicine - domestic and international trade; Germany pricing reforms; Poland market access; Greece pricing reform; Romania cost-containment; CEE cost-containment; Anti-Counterfeiting; Turkey policy; PNTR for Russia; Veterinary Medicine
Food safety; Veterinary medicine; Antibiotic issues; Trade
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2011 · second_quarter · Q2
Trans-Pacific Partnership Agreement; Korean Free trade Agreement; TPP IP/Market Access; ASEAN Countries Market Access/IP; IMF Policy on Greece; Veterinary medicine - domestic and international trade; Germany pricing reforms; Poland market access; Greece pricing reform; Romania cost-containment; CEE cost-containment; Anti-Counterfeiting; Turkey policy; PNTR for Russia
Food safety; Food safety intervention
America Invents Act (patent reform)(HR 1249); Anti-Counterfeiting; Patient safety
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2011 · first_quarter · Q1
Food Safety, Veterinary Medicine, Antibiotic Issues, Trade, Veterinary Biologics/Appropriations
TPP IP/Market Access, ASEAN Countries Market Access/IP, Russia PNTR/Data Exclusivity, Veterinary Medicine - S/PS Issues, Germany Pricing Reforms, Poland Market Access, Greece Pricing Reform, Romania Market Access, Spain IP/Pricing, Turkey GMP Issue
Food Safety, Food Safety Intervention
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2010 · fourth_quarter · Q4
Russia DE; Saudi Zyprexa Issue; Mexico IP legislation; Trade issues (S/PS, EU, China, Russia, Korea, Vietnam); IP Issues; China IPR, US-Japan Trade Forum and Reform; KORUS and Krean Reform; Taiwan Reforms; Turkey GMP Inspection Requirement; Germany Pricing Reform; Poland Market Access; Greece Pricing Reform; Italy Market Access; Veterinary Medicine - S/PS Issues
Food safety (S 510); Food safety interventions
Food Safety (S 510); PAMTA (S 619, R 1549); Veterinary Medicines/Appropriations; Child Nutrition (S 3307), Veterinary Capabilities Legislation-Loan Repayment (HR 2999)
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2010 · third_quarter · Q3
Russia DE; Saudi Zyprexa Issue; Mexico IP legislation; Trade issues (S/PS, EU, China, Russia, Korea, Vietnam); IP issues; China IPR; US-Japan trade forum and reform; KORUS and Korean reform; Taiwan reforms; Turkey GMP inspection requirement; Germany pricing reform, Poland market access, Greece pricing reform, Italy market access
Food safety (S 510); PAMTA (S 619, HR 1549); Veterinary Medicine Public Health/Loan Repayment Act (S 3621. HR 2999); Veterinary Medicines; Appropriations
Food Safety (S 510); Food safety interventions - USDA
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2010 · second_quarter · Q2
Veterinary medicine / antibiotic legislation (HR 1459, HR 2400, S 619) / biologics; food safety
China IPR; US-Japan trade forum and reform; KORUS and Korean reforms; Taiwan reforms; Turkey GMP inspection requirement; Veterinary medicine / CODEX; Germany pricing reforms; Poland market access; Greece pricing reform; Italy market access
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2010 · first_quarter · Q1
Veterinary medicine/antibiotics (S 619 & HR 1549), CVB budget; food safety; Child Nutrition Act reauthorization; PAMTA (HR 1549)
China IP; US-Japan trade and reforms; KORUS; Korea reform; Taiwan reform; HR 252; Veterinary medicine trade matters; Brazil WTO Cotton case; Special 301
Medicare reimbursement and coverage policies; Healthcare reform (HR 3590 & HR 4872); food safety; Patient Protection and Affordable Care Act (HR 3590); FOB provisions (HR 3200)
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2009 · fourth_quarter · Q4
Child Nutrition Reauthorization (HR 2997); Food Safety Modernization Act (S 510); Food Safety Enhancement Act (HR 2749)
Veterinary medicine; Preservation of Antibiotics for Medical Treatment Act (HR 1549, S 619); Food Safety Modernization Act (S 510); Food Safety Enhancement Act (HR 2749); Strategies to Address Antimicrobial Resistance Act (HR 2400)
Anti-counterfeiting; Anti-counterfeiting Trade Agreement (ACTA); Ambassadorial nominations for the UN, US_ASEAN Summit; Canada S. 242 and intellectual property (IP); Mexico IP; Peru FTA; Columbia FTA; Algeria access; UK pricing; Germany HC reform; Saudi Arabia access/IP; Cuba sanctions; Argentina access and IP; Poland WTO; Russia WTO; Turkey access; Brazil trade negotiations; Japan pricing and regulatory reform; China IPR; Korea pricing reform and FTA; Taiwan pricing reform; Agriculture Appropriations/Trade Provisions (HR 2997)
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2009 · third_quarter · Q3
Preservation of antibiotics for medical treatment act (HR 1549, S 619); Food safety enhancement act (HR 2749); Food safety modernization act (S 510); Strategies to address antimicrobial act (HR 2400); Veterinary services investment act (S 1709, HR 3519)
Child nutrition act reauthorization; General food safety and intervention issues
2010 Market access program and foreign market development funding
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2009 · second_quarter · Q2
Antibiotic legislation (HR 1549, S 619)
Child Nutrition Act Reauthorization, Food Safety (S 510, HR 2749)
Appropriations -- Agriculture/FDA
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2009 · first_quarter · Q1
Veterinary Medicine Market Access; Czech Republic (market access & pricing reform); European Union (Pharmaceutical Package legislation); Finland (IP); Germany (pricing & health care reform); Italy (pricing & health care reform); Norway (IP & market access); Poland (market access); Slovakia (IP & market access); Sweden (pricing & health care reform); United Kingdon (pricing & health care reform); Anti-Counterfeiting Trade Agreement; Latin America Free Trade Agreements; (CONTINUED ON NEXT PAGE) Canada (Pharmaceutical Market Access and Drug Safety Act - S 242 & access restrictions & IP); Cuba (omnibus bill & sanctions); Mexico (IP & market access); Brazil (IP & market access); Algeria (IP & access restrictions); Tunisia (IP & access restrictions); Egypt (IP); Saudia Arabia (IP & access restrictions); Peru (FTA Implementation); Argentina (IP & access restrictions); Chili (IP); Turkey (IP & access restrictions); Russia (IP & WTO accession); Israel (IP); Columbia (IP); South Africa (access restrictions); Japan (pricing & regulatory reform); China (anti-counterfeiting & pricing reform); Taiwan (pricing reform & IP); Korea (pricing reform); Thailand (CL); Indonesia (investment decree); Philippines (pricing reform);
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2008 · fourth_quarter · Q4
Veterinary medicine (access)
EU Duties; Market Access (China, Germany, Czech Republic, Italy, Norway, Poland, United Kingdom, Indonesia); Intellectual Property (Finland, Norway, China, Philippines); Pricing Reform (Czech Republic, Japan, Korea, Thailand)
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
Food safety; Veterinary medicine; Antibiotic issues; Trade;
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
Agriculture Appropriations/MAP-FMD Funding (HR 2997)
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
Japan bilateral trade architecture; reimbursement and regulatory reform, China IP; Korea FTA reimbursement & pricing reform; Taiwan TIFA and reimbursement & pricing reform; Indonesia investment decree; Philippines pricing reform; Thailand healthcare system reform; Agriculture (HR 2997, S 1406); Rural development; Food and Drug Administration Appropriations Act for 2010; China meat & poultry issues; Russia meat & poultry issues; UK meat & poultry issues; CODEX Alimentarius; Turkey pricing; Russia IP; A;geria market access; Brazil IP; Mexico IP; Argentina IP; Chile IP; Columbia IP; Peru IP; Isreal IP; Saudi Arbia pricing and IP
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), Natl Economic Council (NEC), Natl Security Council (NSC), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
Veterinary Antibotics (S 619 & HR 1549)
Child Nutrition Reauthorization
Filing targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Security Agency (NSA), Natl Security Council (NSC), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)